Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-27 Sale | 2023-10-31 5:00 pm | Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer | 12,778 | $9.82 | $125,480 | 130,079 (Direct) | View |
| 2023-10-27 Sale | 2023-10-31 5:00 pm | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 50,012 | $9.82 | $491,118 | 342,845 (Direct) | View |
| 2023-10-23 Purchase | 2023-10-25 4:15 pm | Ambrx Biopharma Inc. | AMAM | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 1,307,311 | $6.9911 | $9,139,542 | 11,231,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Disposition | 2024-03-07 7:23 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Hermans Kate Director | 87,142 | $0 | 0 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 7:19 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Loesberg Janet Director | 57,142 | $0 | 0 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 5:46 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 2,039,487 | $0 | 0 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 5:45 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Glover Stephen C. Director | 50,356 | $0 | 0 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 5:43 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Aromando Andrew Chief Operating Officer | 526,998 | $0 | 0 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 5:41 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer | 785,590 | $0 | 0 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 5:36 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | DALESANDRO MARGARET Director | 27,976 | $0 | 0 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 5:34 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | MAIER PAUL V Director | 57,142 | $0 | 0 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-11 5:19 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Aromando Andrew Chief Operating Officer | 100,000 | $0 | 109,263 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-11 5:17 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer | 50,000 | $0 | 545,776 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-11 5:15 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 750,000 | $0 | 1,363,332 (Direct) | View |